Axis Bio is a preclinical contract research organisation with specialist capabilities in oncology, inflammation and respiratory diseases. <br/><br/> Services range from in vitro efficacy and mechanistic studies, to in vivo target engagement, with each study tailored to the unique requirements of the client. <br/><br/> Our clients are spread across the globe and include pharmaceutical and biotech businesses, university-based research organisations and virtual/semi-virtual development companies. <br/><br/> We listen, guide and advise clients through every step of the preclinical efficacy testing process, to deliver clear and robust results in a timely and cost-effective manner. This approach applies whether we are simply carrying out the in-life phase of a study or providing a complete package of analysis including flow cytometry analysis, bioanalysis and blood analysis, along with a detailed interpretation of results and recommendations.